Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Batumalaie, Kalaivani ^a   Amin, Muhammad Arif ^a   Murugan, Dharmani Devi ^a   Sattar, Munavvar Zubaid Abdul ^b   Abdullah, Nor Azizan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; I KAPPA B KINASE; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PALMITIC ACID; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; WITHAFERIN A; WITHANOLIDE;

ANIMAL; CELL SURVIVAL; DRUG EFFECT; ENDOTHELIUM; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; ENDOTHELIUM; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; I-KAPPA B KINASE; INSULIN RESISTANCE; INTERLEUKIN-6; NF-KAPPA B; OXIDATIVE STRESS; PALMITIC ACID; PHOSPHORYLATION; RATS; TUMOR NECROSIS FACTOR-ALPHA; WITHANOLIDES;

EID: 84973299035     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27236     Document Type: Article

References (48)

1. Bray, G. A. Medical consequences of obesity. J Clin Endocrinol Metab 89(6), 2583-2589 (2004).
2. Kim, J. A., Montagnani, M., Koh, K. K. & Quon, M. J. Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms. Circulation 113(15), 1888-1904 (2006).
3. Maloney, E. et al. Activation of NF-kappa B by palmitate in endothelial cells: A key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Throm Vas Biol 29(9), 1370-1375 (2009).
4. Caballero, A. E. Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease. Obes Res 11(11), 1278-1289 (2003).
5. Lacraz, G. et al. Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat. PLoS One 4(9), e6963 (2009).
6. Assar, M. E. et al. FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1alpha activation. Br J Pharmacol 172(5), 1277-1291 (2015).
7. Kwon, H. & Pessin, J. E. Adipokines mediate inflammation and insulin resistance. Front Endocrinol 4, 71 (2013).
8. Alam, N. et al. Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complem Altern Med 12, 175 (2012).
9. Gupta, V. K., Singh, G. D., Surjeet. S. & Kaul, A. Medicinal plants: Phytochemistry, Pharmacology and Therapeutics, Vol. 2, 1-429 (Daya Pub. House, Delhi. 2010).
10. Kaileh, M. et al. Withaferin A strongly elicits Iκ B kinase β hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 282(7), 4253-4264 (2007).
11. Grover, A., Shandilya, A., Bisaria, V. S. & Sundar, D. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: A case study on human and bovine proteasomes. BMC Genomics 11 (Suppl 4), S15 (2010).
12. SoRelle, J. A. et al. Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation. Diabetologia 56(4), 814-824 (2013).
13. Halliwell, B. Oxidative stress in cell culture: an under-appreciated problem? FEBS Letters 540, 3-6 (2013).
14. Halliwell, B. Cell culture, oxidative stress and antioxidants: Avoiding pitfalls. Biomedical Journals 37(3), 99-105 (2014).
15. Boden, G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diabetes Rep 6(3), 177-181 (2006).
16. Awad, A. B. & Bradford, P. G. In Adipose tissue and inflammation, Ch. XII, ebook (Taylor & Francis, 2010).
17. Egnatchik, R. A., Leamy, A. K., Noguchi, Y., Shiota, M. & Young, J. D. Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. Metabolism 63(2), 283-295 (2014).
18. Zhang, D. Y. et al. Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation. J Diabetes 5(1), 13-24 (2013).
19. Batumalaie, K. et al. Effect of gelam honey on the oxidative stress-induced signaling pathways in pancreatic hamster cells. Inter J Endocrinol 2013, doi: 10.1155/2013/367312 (2013).
20. Qatanani, M. & Lazar, M. A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21(12), 1443-1455 (2007).
21. Kim, J. J. & Sears, D. D. TLR4 and Insulin Resistance. Gastroent Res Pract 2010, doi: 10.1155/2010/212563 (2010).
22. Li, X., Commane M., Jiang, Z. & Stark, G. R. IL-I induced NF-kappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci USA 98, 4461-4465 (2001).
23. Szarc Vel Szic, K. et al. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS One 9, e87850 (2014).
24. Park, J. W. et al. A leaf methanolic extract of Wercklea insignis attenuates the lipopolysaccharide-induced inflammatory response by blocking the NF-kappa B signaling pathway in RAW 264.7 macrophages. Inflammation 35(1), 321-331 (2012).
25. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12), 1821-1830 (2003).
26. Badawi, A. et al. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 3, 173-186 (2010).
27. Jiang, Z. Y. et al. Characterisation of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104, 447-457 (1999).
28. Cusi, K. et al. Insulin resistance differentially affects PI3-kinase and MAP-kinase mediated signaling in human muscle. J Clin Invest 105, 311-320 (2000).
29. Montagnani, M. & Quon, M. J. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2, 285-92 (2000).
30. Muniyappa, R., Iantorno M. & Quon, M. J. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metabol Clin North Am 37(3), 685-711 (2008).
31. Liu, K. I. et al. Diosgenin ameliorates palmitate induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways. Atherosclerosis 223(2), 350-358 (2012).
32. Steinberg, H. O. et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J of Clin Invest 100(5), 1230-1239 (1997).
33. Davda, R. K. et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26(5), 764-770 (1995).
34. Verma, S. & Anderson, T. Fundamentals of endothelial function for the clinical cardiologist. Circulation 105, 546-549 (2002).
35. Kaneto, H., Katakami, N., Matsuhisa, M. & Matsuoka, T. A. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm 2010, doi: 10.1155/2010/453892 (2010).
36. Baron, A. D., Laakso, M., Brechtel, G. & Edelman, S. V. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73(3), 637-643 (1991).
37. Yki-Jarvinen, H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38(12), 1378-1388 (1995).
38. Cardillo, C. et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100, 820-825 (1999).
39. Arcaro, G. et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105(5), 576-582 (2002).
40. Koppenol, W. H., Moreno J. J., Pryor, W. A., Ischiropoulos, H. & Beckman, J. S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5, 834-842 (1992).
41. Milstien, S. & Katusic, Z. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun 263, 681-684 (1999).
42. Venugopal, S. K., Devaraj, S., Yuhanna, I., Shaul P. & Jialal, I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106, 1439-1441 (2002).
43. Verma, S. et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106, 913-919 (2002).
44. Corda, S., Laplace, C., Vicaut, E. & Duranteau, J. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Resp Cell Mol 24(6), 762-768 (2001).
45. Deisher, T. A. et al. The role of protein kinase C in the induction of VCAM-J expression on human umbilical vein endothelial cells. FEBS Lett 331, 285-290 (1993).
46. Zhang, C. et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol 40, 247-257 (2006).
47. Wimalasundera, R., Fexby, S., Regan, L., Thom, S. A. & Hughes, A. D. Effect of tumour necrosis factor-α and interleukin 6 on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 138, 1285-1294 (2003).
48. Loh, W. M. et al. Des-aspartate angiotensin I (DAA-I) reduces endothelial dysfunction in the aorta of the spontaneously hypertensive rat through inhibition of angiotensin II-induced oxidative stress. Vascul Pharmacol 71, 151-8 (2015).